Exponent, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EXPO research report →
Range $72 – $72
Price Chart
About the company
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health.
- CEO
- Catherine Ford Corrigan
- IPO
- 1990
- Employees
- 1,012
- HQ
- Menlo Park, CA, US
Get TickerSpark's AI analysis on EXPO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.37B
- P/E
- 31.11
- Fwd P/E
- 30.08
- PEG
- 2.84
- P/S
- 5.32
- P/B
- 11.72
- EV/EBITDA
- 22.04
- Div Yield
- 1.76%
- Gross Margin
- 24.60%
- Op Margin
- 20.17%
- Net Margin
- 17.67%
- ROE
- 31.48%
- ROIC
- 18.24%
Latest fiscal year · YoY change
- Revenue
- $582.01M+4.2%
- Gross Profit
- $145.31M+2.1%
- Op Income
- $119.79M
- Net Income
- $106.01M-2.7%
- EPS
- $2.08-2.3%
- OCF Growth
- -8.9%
- FCF Growth
- -11.1%
- 52W High
- $81.95
- 52W Low
- $51.91
- 50D MA
- $62.33
- 200D MA
- $67.02
- Beta
- 0.68
- RSI (14)
- 63
- Avg Volume
- 563.22K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Exponent delivered another strong quarter with double-digit revenue and earnings growth, driven by expanding AI-related user research and steady demand in reactive failure-analysis work, while raising full-year guidance.· July 30, 2026
- Q2 total revenue rose 21% to $171.6 million; net revenues rose 12% to $148.9 million.
- Net income increased 11% to $29.4 million and diluted EPS rose 15% to $0.60.
- EBITDA increased 16% to $42.7 million, with margin expanding to 28.7% of net revenues from 27.8%.
- User research was a major driver, including a large study that reached about 4% of net revenues versus 2% expected.
- Management raised 2026 guidance for net revenue growth to 9% to 10% and EBITDA margin to 27.8% to 28.1%.
For Q2 2026, total revenues increased 21% year over year to $171.6 million, while net revenues increased 12% to $148.9 million. Net income rose 11% to $29.4 million, and diluted EPS increased 15% to $0.60 versus $0.52 a year ago. EBITDA increased 16% to $42.7 million, with margin at 28.7% of net revenues versus 27.8% in Q2 2025. Billable hours were approximately 390,000, up 8%; average technical full-time employees were 1,012, up 6%; utilization was 74% versus 72%; and realized rates increased about 4%. For the third quarter, management expects net revenues to be up 8% to 10% and EBITDA margin to be 28.0% to 28.5% of net revenues. For full-year 2026, Exponent raised guidance to 9% to 10% net revenue growth and 27.8% to 28.1% EBITDA margin. The company also expects full-year utilization of 72.5% to 73%, realized rate increases of 3.5% to 4%, capex of $12 million to $14 million, and tax rate of 28.5%.
Catherine Corrigan said demand is being driven by long-term themes: rapid technological innovation, more complex products and systems, higher energy demand, resilient infrastructure needs, and rising expectations for safety, reliability, and performance. She emphasized that Exponent is increasingly valuable when AI moves into physical products and real-world systems, where human factors, regulatory issues, and failure analysis intersect. Her tone was confident and focused on Exponent’s differentiated multidisciplinary role.
Eric Anderson highlighted that Q2 growth benefited from reimbursable user research spending, including a large study that ended up representing about 4% of net revenues instead of the 2% expected. He cited EBITDA of $42.7 million, a 28.7% margin, and noted margin expansion despite higher compensation, G&A, and infrastructure investments. On capital allocation, he said the company spent $67.4 million on buybacks in the quarter at an average price of $59.88, paid $14.8 million in dividends, and returned $272 million to shareholders over the last 12 months; the board also added $50 million to the repurchase authorization. He added that cash is now at a lower but still comfortable level, with a stated willingness to operate in a $50 million to $70 million cash range.
Analysts focused on how AI is showing up in both proactive and reactive work, and management said it is contributing to both. On the reactive side, Catherine pointed to advanced driver assistance litigation, data-center failures, battery energy storage, cooling systems, and other infrastructure-related investigations; on the proactive side, user research for AI-enabled products remains especially strong. Questions also centered on the expanding scope of user research and whether utilization could rise further, with management saying the large study expanded meaningfully but should normalize to about 2% of revenues for the rest of the year, while second-half utilization is expected to stay around 74% to 75% in Q3 and lower seasonally in Q4. A final topic was repurchases, and Eric said the company will keep buying back enough stock to offset dilution, with more aggressive buybacks when the stock pulls back, but at a lower pace than in the first half of 2026.
The call showed broad demand across both proactive and reactive businesses, with especially strong momentum in AI-enabled user research and utility/infrastructure work. Management also sounded confident that Exponent’s multidisciplinary capabilities, pricing power, and recruiting advantages are becoming more differentiated as work gets more complex.
A large part of the quarter benefited from an unusually big user research study, and management said that project will moderate to about 2% of revenues for the rest of the year. Buybacks are also likely to slow from the recent pace because cash is lower, and Q4 utilization should fall seasonally due to holidays and fewer working days.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.8%
- Shares Outstanding
- 48.51M
- Float Shares
- 47.93M
of shares held by institutions
364 13F filers
Congressional trading
Senate and House stock disclosures for EXPO, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 6.18M | ▲ 116.14K |
| Vanguard Group Inc | 5.14M | ▼ 107.74K |
| Kayne Anderson Rudnick Investment Management LLC | 4.00M | ▲ 109.38K |
| Vanguard Capital Management LLC | 2.18M | ▼ 30.44K |
| State Street Corp | 1.94M | ▲ 54.11K |
| Geode Capital Management, LLC | 1.75M | ▲ 100.42K |
| Geneva Capital Management LLC | 1.41M | ▼ 390.33K |
| Royce & Associates LP | 1.32M | ▲ 178.22K |
| Conestoga Capital Advisors, LLC | 1.27M | ▼ 640.80K |
| Morgan Stanley | 1.21M | ▲ 142.00K |
| Aqr Capital Management LLC | 1.14M | ▲ 163.57K |
| First Trust Advisors LP | 1.08M | ▲ 118.56K |
Held by 316 ETFs
Biggest fund positions in EXPO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 17, 26 | Corrigan Catherine | other | 2,379 |
| Aug 17, 26 | Corrigan Catherine | sell | 1,707 |
| Aug 17, 26 | Corrigan Catherine | other | 2,379 |
| Jul 28, 26 | Corrigan Catherine | other | 12,665 |
| Jul 28, 26 | Corrigan Catherine | other | 12,665 |
| Jul 15, 26 | Corrigan Catherine | other | 2,379 |
| Jul 15, 26 | Corrigan Catherine | sell | 1,737 |
| Jul 15, 26 | Corrigan Catherine | other | 2,379 |
| Jun 25, 26 | Corrigan Catherine | other | 7,872 |
| Jun 25, 26 | Corrigan Catherine | other | 7,872 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EXPO coverage
Recent articles, reports, and earnings notes.
No research on EXPO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EXPO report →Are Business Services Stocks Lagging Exponent (EXPO) This Year?
zacks.com · Aug 20
New EXPO® XL Marker Creates Bigger, Bolder Writing for Better Classroom Visibility From the Front Row to the Back
prnewswire.com · Aug 19
Wall Street Analysts Predict a 25.65% Upside in Exponent (EXPO): Here's What You Should Know
zacks.com · Aug 3
Exponent, Inc. (EXPO) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 30
Exponent Q2 Earnings Call Highlights
marketbeat.com · Jul 30
Exponent (EXPO) Surpasses Q2 Earnings and Revenue Estimates
zacks.com · Jul 30
Exponent Declares Regular Quarterly Dividend for Q3 2026 and Increases Stock Repurchase Authorization by $50 Million
globenewswire.com · Jul 30
Exponent Reports Second Quarter 2026 Financial Results
globenewswire.com · Jul 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.